Christopher Chen serves as Director of the Company. Dr. Chen serves as chief executive officer of ChenMed LLC, a physician-led company that aims to bring concierge-style medicine and better health outcomes to seniors. Under Dr. Chen's leadership, ChenMed grew from a handful of South Florida centers to the 59 it operates in eight states today. The senior-focused primary care practice delivers industry-leading health outcomes and patient satisfaction with significantly lower total cost of care. A clinically trained physician, Dr. Chen is board certified in several specialty areas centered on primary care and cardiology and is licensed to practice medicine in several states.
Over the last 22 years, insiders at Magellan Health Inc have traded over $207,355,721 worth of Magellan Health Inc stock and bought 25,726 units worth $1,508,914 . The most active insiders traders include Peter A Feld, James E Murray oraz Mary F Sammons. On average, Magellan Health Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,340,119. The most recent stock trade was executed by James E Murray on 2 January 2022, trading 3,262 units of MGLN stock currently worth $309,857.
Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan Health supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan Health customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.
Magellan Health Inc executives and other stock owners filed with the SEC include: